On the surface, the expansion of HACCP Plans to include [pathogenic E. coli other than O157, also known as “pSTECs”] should be easily accomplished. On closer evaluation, however, there are so many missing pieces, that I for one am finding it difficult to generate reasonable and scientifically based HACCP plans for pSTECs.
One problem is that more research is needed to scientifically validate the numerous beef slaughter interventions for control of pSTECs. The limited studies that have been conducted to date support the concept that intervention for E. coli O157:H7 are also effective for pSTECs http://www.amif.org/research/10-113/ However, specific validation studies are needed to document the reductions for the six regulated pSTECs associated with all slaughter interventions.
Another problem is that it’s much more difficult to design effective testing programs for pSTECs (a group of organisms) than it is for E. coli O157:H7 (a single organism).” —
Testing meat for the “other E. coli’s” (the six Shiga toxin-producing strains, other than O157:H7, that meat processors must now consider “adulterants” in the legal sense) is going to be more difficult than it looks. A column at Meatingplace.com (free subscription) explains some of the nitty-gritty.
On Jan. 4, the Food and Drug Administration proposed banning some extra-label uses of cephalosporins, a category of antibiotics used in farming that are also critical drugs in human medicine.
The 60-day public comment period closes March 6 - that’s today.
Here’s where to comment.
Here’s my original blog post explaining why this ban is so unusual for the FDA, and why it’s a first step in addressing uncontrolled agricultural antibiotic use.
Blaming “Writer’s Block” is wonderful. It removes any responsibility from the person with the “block”. It gives you something to blame, and it sounds fancy.
But it’s probably more honest to think of it as a combination of laziness, perfectionism and Getting Stuck.” —
(go read the whole entry, it’s worth it.)
Old-media nepotism: Getting your kid a publishing contract.
New-media nepotism: Getting your grand-grandmother one?